Evaluation of the use of apixaban in prevention of thromboembolic disease in patients with myeloma treated with iMiDs

被引：0
|
作者：
Gavard, M. [1 ]
Pegourie, B. [2 ]
Pernod, G. [3 ]
Rolland-Neyret, V. [2 ]
机构：
[1] CHU Grenoble Alpes, Delegat Rech Clin & Innovat, Grenoble, France
[2] CHU Grenoble Alpes, Serv Hematol, Grenoble, France
[3] CHU Grenoble Alpes, Serv Med Vasc, Grenoble, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PM2 - 044
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [1] Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs
    Paydas, Semra
    LEUKEMIA & LYMPHOMA, 2008, 49 (08) : 1644 - 1645
  • [2] Risk Assessment of Thromboembolic Disease In Patients Treated For Multiple Myeloma
    Douma, Soukaina
    Naim, Sara
    Benmoussa, Amine
    Berrada, Sophia
    Lamchahab, Mouna
    Khoubila, Nissrine
    Rachid, Mohammed
    Qachouh, Meryem
    Cherkaoui, Siham
    Madani, Abdellah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S570 - S570
  • [3] Risk factors for thromboembolic events in multiple myeloma patients treated with IMiDs-based therapy while on LMWH prophylaxis
    Leleu, X.
    Iacobelli, S.
    Barrois, A.
    van Os, M.
    Clark, L.
    Moreau, P.
    Dib, M.
    Caillot, D.
    Niederwieser, D.
    Masszi, T.
    Fontan, J.
    Michallet, M.
    Doyen, C.
    Hajek, R.
    Onida, F.
    Ludwig, H.
    de Witte, T.
    Schoenland, S.
    Gahrton, G.
    Morris, C.
    Kroeger, N.
    Garderet, L.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S205 - S206
  • [4] USE OF PLAQUENIL FOR PREVENTION OF THROMBOEMBOLIC DISEASE IN ORTHOPEDIC PATIENTS
    CHRISMAN, OD
    SNOOK, GA
    WILSON, TC
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1975, 57 (08): : 1171 - 1171
  • [5] Evaluation of Apixaban Use in Patients With Advanced Kidney Disease
    McClain, Conner
    Buckallew, Amanda R.
    Armbruster, Anastasia L.
    JOURNAL OF PHARMACY TECHNOLOGY, 2024, 40 (04) : 171 - 177
  • [6] Pharmacoeconomic aspects of apixaban for prevention of thromboembolic events in patients with atrial fibrillation
    Rudakova, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (01) : 60 - 62
  • [7] USE OF ANTICOAGULANTS IN PREVENTION OF VENOUS THROMBOEMBOLIC DISEASE IN POSTOPERATIVE PATIENTS
    BELDING, HH
    ARCHIVES OF SURGERY, 1965, 90 (04) : 566 - &
  • [8] Risk Factors of Thromboembolic Events in Multiple Myeloma Treated with IMiDs-Based Therapy While on LMWH Prophylaxis
    Leleu, Xavier
    Iacobelli, Simona
    Barrois, Alain
    Pelle, Benjamin
    Clark, Liz
    Boyle, Eileen
    Moreau, Philippe
    Dib, Mamoun
    Caillot, Denis
    Niederwieser, Dietger
    Masszi, Tamas
    Fontan, Jean
    Doyen, Chantal
    Hajek, Roman
    Onida, Francesco
    Ludwig, Heinz
    de Witte, Theo M.
    Gahrton, Gosta
    Morris, Curly T. C. M.
    Garderet, Laurent
    BLOOD, 2011, 118 (21) : 1434 - 1434
  • [9] Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study
    Pegourie, Brigitte
    Karlin, Lionel
    Benboubker, Lotfi
    Orsini-Piocelle, Frederique
    Tiab, Mourad
    Auger-Quittet, Sophie
    Rodon, Philippe
    Royer, Bruno
    Leleu, Xavier
    Bareau, Benoit
    Cliquennois, Manuel
    Fuzibet, Jean-Gabriel
    Voog, Eric
    Belhadj-Merzoug, Karim
    Decaux, Olivier
    Rey, Philippe
    Slama, Bohrane
    Leyronnas, Cecile
    Zarnitsky, Charles
    Boyle, Eileen
    Bosson, Jean Luc
    Pernod, Gilles
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (06) : 635 - 640
  • [10] ULTRA-LOW DOSE APIXABAN IN SECONDARY PREVENTION OF VENOUS THROMBOEMBOLIC DISEASE
    Sharifi, Mohsen
    Ezeume, Chukwuemeka
    Sharifi, Iman
    Schleifer, Scott
    Snyder, Robert
    Foroughi, Mani
    White, Emily
    Sarraf, Arya
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2259 - 2259
12345